i+academy

A national medicines policy is the combined effort of a country (through policies, guidelines, strategies or plans) to ensure the availability, affordability and rational use of medicines that are safe, effective and of good quality. The policy usually contains provisions on the regulatory body (national regulatory authority) that develops and implements legislation to this end.

NCB is an acronym for National Competitive Bidding, a procurement method.

NDRA is the acronym for national drug regulatory authority. Also known as national regulatory authority (NRA) or national medicines regulatory authority (NMRA). 

Nombre de Jours de Rupture des Stocks

NMP is the acronym for National Medicines Policy. National medicines policy is the combined effort of a country (through policies, guidelines, strategies or plans) to ensure the availability, affordability and rational use of medicines that are safe, effective and of good quality. It usually contains provisions on the regulatory body (national regulatory authority) that develops and implements legislation and regulation to ensure the safety, efficacy and quality of medicines.

Non-routine data sources are sources that provide data on a non-frequent periodic basis (usually annually or even less frequently). Examples are large-scale household surveys, smaller scaled ad-hoc household surveys, special studies and national censuses.

NRA is the acronym for national regulatory authority.

Numérateur